COVID-SEROKLIR
Mark Identification

COVID-SEROKLIR

Serial Number

90130724

Filing Date

Aug 21, 2020

Trademark by

KANTARO BIOSCIENCES LLC

Classification Information

Diagnostic preparations for medical purposes for use in hospitals; Diagnostic agents, preparations and substances for medical or veterinary purposes; Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens; Assays, reagents, media, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical and clinical purposes; Diagnostic reagents for serologic tests of infections for medical and clinical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Kits and components for use in diagnostic testing for medical or veterinary use; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical and clinical test kits for coronavirus, SARS-CoV-2 and COVID-19 diagnosis and monitoring; Diagnostic preparations for medical and clinical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Preparations and substances for the diagnosis, prevention and treatment of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders

Pharmaceuticals